Anaesthesia & Critical Care Medicine Journal

Citation: Gupta N, et al. Anesthetic Concerns in Patients Receiving Preoperative Opioids: a Review. Ane Cr Care Med J 2016, 1(2): 000107.

Anesthetic Concerns in Patients Receiving Preoperative Opioids: a Review

Gupta N1*, Gupta A2, Garg R1and Kumar V1
1Department of Onco Anesthesia and Palliative Medicine, DRBRAIRCH, AIIMS, India
2Department of Anesthesia, Chacha Nehru Bal Chikitsalya, India
Mini review
Volume 1 Issue 2 - 2016
Received Date :July 21, 2016
Published Date :August 02, 2016

*Corresponding author: Nishkarsh Gupta, Assistant Professor, Department of Onco Anesthesia and Palliative Medicine, DRBRAIRCH, AIIMS, New Delhi, Email:


Objectives: To evaluate the advantages and disadvantages along with comparison of results of endoscopic septoplasty over conventional septoplasty.

Methods: The prospective type of study was conducted in a tertiary referral centre and a total of 60 patients between the ages group of 18-35 years having symptomatic deviated nasal septum and refractory to conservative medical treatment were included in the study while patients with uncontrolled hypertension or diabetes, having upper respiratory tract infection or allergic rhinitis were excluded from the study. Patients were divided into two groups: Group A-consisted of 30 patients, in whom conventional septoplasty was done and Group B-consisted of 30 patients, in whom endoscopic septoplasty was performed. Post-operative assessment was carried out at 48hrs, 15days, 1 month and 3 months after the surgery.

Results: 24 (80%) patients of Group A had improvement in nasal obstruction, 18 (90%) showed symptomatic relief from nasal discharge and headache was relieved in 17 (85%) patients. In Group B, 27 (90%) patients had improvement in nasal obstruction, 20 (90.9%) showed relief from nasal discharge and headache was relieved in 20 (95.2%) patients. Residual septal deviation was seen only in 3 (10%) patient of Group A. 3 (10%) cases developed synechiae in Group A as compared to 1 (3.3%) case in Group B. Lip oedema developed only in 3 (10%) of cases in Group A. Bleeding from nose requiring repacking was seen in 3 (10%) patients of Group A and 1 (3.3%) in Group B.

Conclusion: Endoscopic septoplasty showed better results as compared to conventional septoplasty as endoscope gives better illumination and improved access to deviated nasal septum and allows limited incision, limited flap elevation, and achieves correction with least resection and thus reducing the post-operative complications.

Keywords:Septoplasty; Endoscopic; Conventional

Full Text

Patients suffering from cancer or non cancer pain syndromes are frequently receiving opioids for pain management in the preoperative period [1,2]. Anesthesiologist commonly encounters patients on chronic opioids medication for surgery and has to manage behavioral, psychological and pharmacological aspects. It is important for anesthesiologist to know about effects and management of chronic opioids therapy because opioids are an important component of postoperative pain therapy, an adequate opioids dose in the perioperative period should be maintained to prevent opioids withdrawal and it can be challenging to revert to preoperative opioids regimen after surgery [1].

In one of the surveys, 67% of orthopedic patients and 25% of general surgical patients were receiving long term opioids treatment [3]. The patients with cancer on chronic opioids therapy (daily oral morphine dose 90 to 360 mg) often require 3-4 times morphine given via a continuous epidural infusion or intermittent intravenous bolus for breakthrough pain after surgery compared with opioids-naive patients. Rapp et al. [4] have also reported a 3-fold greater postoperative opioid requirement in chronically opioids-consuming patients [4]. In addition, regular administration of strong opioids like morphine leads to side effects like nausea, constipation, sedation and respiratory depression. In addition these patients may have opioid induced dependence (physical/psychological), addiction and hyperalgesia and need to be managed carefully in the perioperative period [1,2].

A patient on chronic opioid therapy may develop behavioral changes like loss of control over use, compulsive use, continued use despite causing harm and craving [2,5].

Patients may also be physically dependent on the drug and show symptoms on withdrawal due to fall in plasma levels and decreased receptor occupancy. This may be due to sudden Withdrawal of drug, rapid reduction of dose or administration of an antagonist. In the perioperative period if inability to maintain baseline opioid consumption may precipitate withdrawal.

In addition patients develop tolerance and may require greater dose of opioid to achieve the same analgesic effect [6,7].The degree of tolerance depends upon duration and amount of opioid exposure and receptor kinetics. It may occur due to learned compensatory mechanisms in individuals (learned), altered distribution and metabolism of drug (pharmacokinetic) and decrease in number of opioid receptors (pharmacodynamic). Opioids are metabolized by cytochrome P450 which can be induced by barbiturates and antiepileptic drugs [6]. Chronic exposure of such drugs can increase opioid metabolism and cause tolerance.

Also, chronic administration of opioid may paradoxically increase sensitivity to painful and nonpainful stimuli. This occurs due to neurochemical changes in the central nervous system by neuropeptides to restore equilibrium in response to increased anti-nociceptive activation by opioid administration [7]. This is typically seen after rapid dose escalation of opioids and responds to a reduction in opioid dose.

Prolonged opioid usage in preoperative period may affect the immune function, by inhibit Tcell and macrophage activity, and can result in adrenocortical suppression. These may affect the surgical outcome and cancer recurrence and is discussed in detail in other part of this chapter [7,8].

Peri-operative Management

In patients on long-term opioids, it is essential to identify relevant problems and formulate an appropriate management plan. At present, no data or guidelines are available to predict individual postoperative opioid requirements based on preoperative opioid dose.

Key Factors in Pre-operative Assessment of patient on strong opioids

These patients may be anxious and need to be educated, counselled and reassured.

 A detailed history must be taken to get the correct preoperative opioid usage. Some patients may be abusing the opioid drugs and it may be difficult to ascertain the correct opioid doses.

 Baseline pain assessment should be done to monitor the signs of withdrawal.

 Patients requiring >30mg intravenous morphine equivalent per day for over 1 month may develop tolerance.

 Regular doses of opioid and other adjuvant analgesics need to be continued on morning of surgery.

 Patients requirements may increase up to 4 times the baseline in the postoperative period and analgesia may be required for a longer period.

 A dosing less than required may precipitate withdrawal and may be difficult to diagnose in the perioperative period.

 In case oral route is not possible, an alternative drug/ route ( IV, transdermal or epidural) route may be utilised after calculating equivalent dosing.

 No single anaesthetic technique can be prescribed to such patients. The anaesthetic technique need to be individualised depending on surgical and patient factors.

 Regional anaesthesia alone or with general anaesthesia improves tissue perfusion and reduces opioid requirement.

 Even central opioid receptors are reduced in such patients and an increased dose of the opioids are required form central neuraxial route. Moreover, an additional oral/parenteral administration may be required for satisfactory pain relief [9,10].

Other Strategies Patient controlled analgesia

The use of patient controlled analgesia (PCA) can be a good alternative for customized dosing above background opioid therapy in such patients. Depending upon preexisting patient’s requirement a large bolus on demand may be set and adjusted to effect on an individual basis [10,11]. This will allow autonomy to the patient and requirement can be reassessed to titrate the effect further.

Regional blocks

Analgesia can be supplemented by local anaesthetics with adjuvant given through peripheral/ central neuraxial blocks [11,12]. The common blocks that may be used in once surgeries are mentioned in the table.

Multimodal analgesia

In immediate postoperative period nociceptive pain has multiple mechanisms and addition of other analgesics may provide benefit [13].

a) Opioid rotation: patients exhibit inter individual variation in response to different opioids and instead of rapidly escalating the doses of opioids, switching to an alternative strong opioids in equianalgesic doses may be beneficial. This opioid rotation improves pain relief in up to 50% of patients.

b) Ketamine: is NMDA receptor antagonist and helps in reversing opioid tolerance. It may be given as a continuous infusion (5-15 mg/hr) in the immediate pre-operative period and continued for 24-48 hours post-operatively [14,15]. Patients on Ketamine should be monitored for hallucinations (50% incidence) and other vital parameters on regular basis.

c) Clonidine is an agonist at the Alpha-2 adrenoceptor. It augments the effects of opioid drugs, decreases opioid withdrawal reactions and reduces the neurohumeral stress response to surgery. It may be given by the intravenous or epidural route in the dose of 1-2 mcg/kg peri-operatively to enhance analgesia.

d) Paracetamol and NSAID’s are simple analgesics sand have significant opioid sparing effects. In absence of any contra-indications, all patients should receive them in the immediate postoperative period [13].

e) Gabapentin is an anticonvulsant that acts upon the α2δ subunit of calcium channels and at the GABAB receptor. Gabapentin in doses of either 600 or 900mg pre-operatively reduces morphine requirements and its side-effects such as nausea and vomiting in the post-operative period.

  1. American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine. Definitions related to the use of opioids in the treatment of pain.
  3. Taylor DA, Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297(1): 11-18.
  4. Clark JD (2002) chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 23(2): 131-137.
  5. Rapp SE, Ready LB, Nessly ML (1995) Acute pain management in patients with prior opioid consumption: A case-controlled retrospective review. Pain 61(2): 195-201.
  6. Fernandes M, Kluwe S, Coper H (1977) The development of tolerance to morphine in the rat. Psychopharmacology 54: 197-201.
  7. Colfer K (2008) Acute pain management in the opioid-tolerant. Program and abstracts of the American Society for Pain Management Nursing 18th Annual National Conference; September 3-6 Tucson, Arizona.
  8. Carroll IR, Angst MS, Clark JD (2004) Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 29(6): 576-591.
  9. Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81(1): 299-343.
  10. Rozen D, Grass GW (2005) Perioperative and intraoperative pain and anesthetic care of the chronic pain and cancer pain patient receiving chronic opioid therapy. Pain Pract 5(1): 18-32.
  11. Mitra S, Sinatra RS (2004) Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 101(1): 212-227.
  12. Swenson JD, Davis JJ, Johnson KB (2005) Postoperative care of the chronic opioid-consuming patient. Anesthesiology Clin North Am 23(1): 37-48.
  13. De Leon-Casaasola OA, Myers DP, Donaparthi S, Bacon DR, Peppriell J, et al. (1993) A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naive patients. Anesth Analg 76(2): 302-307.
  14. Kehlet H, Dahl JB (1993) The value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anesth Analg 77(5): 1048-1056.
  15. Sveticic G, Gentilini A, Eichenberger U, Luginbuhl M, Curatolo M (2003) Combinations of morphine with ketamine for patient-controlled analgesia. Anesthesiology 98(5): 1195-1205.
  16. Himmelseher S, Durieux M. (2005) Ketamine for perioperative pain management. Anesthesiology 102(1): 211-220.
  17. Cheol Lee, Hyun-Wook Lee, and Ji-Na Kim (2013) Effect of oral pregabalin on opioid-induced hyperalgesia in patients undergoing laparoendoscopic single-site urologic surgery. Korean J Anesthesiology 64(1): 19-24.

Connect us